INTI
Inhibitor Therapeutics, Inc. SEC filings
Every EDGAR filing for Inhibitor Therapeutics, Inc. (INTI), newest first, with AI summaries and stories.
- Ticker
- INTI
- CIK
- 1042418
- Sector
- Biotech and pharma
- Latest filing
- Sep 18
Next: 10-Q expected ~Nov 13 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KInhibitor Therapeutics, Inc.INTILIVE ROUTINEDEF 14AInhibitor Therapeutics, Inc.INTILIVE NOTABLE10-QInhibitor Therapeutics, Inc.INTILIVE ROUTINE4Inhibitor Therapeutics, Inc.INTILIVE James A Mcnulty, insider filing for INTI
James A Mcnulty, reporting · Black Robe Capital LLC, reporting
ROUTINE4Inhibitor Therapeutics, Inc.INTILIVE Ronald E Osman, insider filing for INTI
Ronald E Osman, reporting · Ronald E. Osman Irrevocable Trust III under Agreement dated May 13, 2012, reporting
ROUTINE4Inhibitor Therapeutics, Inc.INTILIVE 3 insider filings
Michelle Yanez, insider filing for INTI
Show all 3
- 4Insider filing for INTI
- 4Insider filing for INTI
- 4Insider filing for INTI
Michelle Yanez, reporting
ROUTINE4Inhibitor Therapeutics, Inc.INTILIVE Michael Allen Jerman, insider filing for INTI
Michael Allen Jerman, reporting
ROUTINE4Inhibitor Therapeutics, Inc.INTILIVE Niraj Vasisht, insider filing for INTI
Niraj Vasisht, reporting
NOTABLE10-QInhibitor Therapeutics, Inc.INTILIVE ROUTINE8-KInhibitor Therapeutics, Inc.INTILIVE ROUTINE8-KInhibitor Therapeutics, Inc.INTILIVE NOTABLE10-KInhibitor Therapeutics, Inc.INTILIVE ROUTINE8-KInhibitor Therapeutics, Inc.INTILIVE NOTABLE10-QInhibitor Therapeutics, Inc.INTILIVE